Is Spironolactone a 'Savior' for Hemodialysis Patients?
A new study found that spironolactone significantly reduced the risk for cardiovascular and cerebrovascular morbidity and death in hemodialysis patients, reports Dr Jeffrey Berns.
Source: Medscape Nephrology Podcast - Category: Urology & Nephrology Authors: Medscape Source Type: podcasts
More News: Cardiology | Cardiovascular | Dialysis | Heart | Hemodialysis | Podcasts | Spironolactone | Study | Urology & Nephrology